Literature DB >> 11273063

Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS.

S Scheer1, P L Chu, J D Klausner, M H Katz, S K Schwarcz.   

Abstract

BACKGROUND: There has been an increase in high-risk sexual behaviour and sexually transmitted diseases (STD) during the time period when highly active antiretroviral therapy (HAART) became widely available. We examined whether taking HAART increased the risk of acquiring an STD--an epidemiological marker of unsafe sex--in people with AIDS.
METHODS: We did a computerised match of people in the San Francisco STD and AIDS registries. People with AIDS who were diagnosed before 1999 and alive in November, 1995, or later, were classified as having had an STD after AIDS diagnosis or not having had an STD after AIDS diagnosis. We used a Cox proportional hazards model to see whether use of antiretroviral therapy was associated with acquiring an STD after AIDS, after adjustment for sex, age, race, HIV-1 risk category, and CD4 count at AIDS diagnosis.
FINDINGS: People with AIDS who had had HAART showed an independent increase in the risk of developing an STD (hazard ratio 4.10; 95% CI 2.84-5.94). Americans of African origin, younger age, and higher CD4 count at AIDS diagnosis were also associated with acquiring an STD after AIDS. The number of people living with AIDS who acquired an STD increased over time from 60 (0.66%) in 1995 to 113 (1.32%) in 1998 (p<0.001).
INTERPRETATION: We have shown that people on HAART are more likely to develop an STD, an epidemiological marker of unsafe sex. More intensive risk-reduction counselling and STD screening for people with AIDS is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11273063     DOI: 10.1016/S0140-6736(00)04007-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Antiretroviral therapy cannot be South Africa's first priority.

Authors:  D J Ncayiyana
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

2.  Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco.

Authors:  Mitchell H Katz; Sandra K Schwarcz; Timothy A Kellogg; Jeffrey D Klausner; James W Dilley; Steven Gibson; William McFarland
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

3.  Sexual risk reduction among HIV-positive drug-using men who have sex with men.

Authors:  Thomas L Patterson; Shirley J Semple
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

Review 4.  Revisiting the ABC strategy: HIV prevention in Uganda in the era of antiretroviral therapy.

Authors:  S Okware; J Kinsman; S Onyango; A Opio; P Kaggwa
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

5.  Risk behaviors of youth living with HIV: pre- and post-HAART.

Authors:  Marguerita Lightfoot; Dallas Swendeman; Mary Jane Rotheram-Borus; W Scott Comulada; Robert Weiss
Journal:  Am J Health Behav       Date:  2005 Mar-Apr

6.  Commercial sex venues: a closer look at their impact on the syphilis and HIV epidemics among men who have sex with men.

Authors:  G Aynalem; L Smith; C Bemis; M Taylor; K Hawkins; P Kerndt
Journal:  Sex Transm Infect       Date:  2006-08-02       Impact factor: 3.519

7.  Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda.

Authors:  Marissa Maier; Irene Andia; Nneka Emenyonu; David Guzman; Angela Kaida; Larry Pepper; Robert Hogg; David R Bangsberg
Journal:  AIDS Behav       Date:  2008-04-04

8.  Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection?

Authors:  J M Stephenson; J Imrie; M M D Davis; C Mercer; S Black; A J Copas; G J Hart; O R Davidson; I G Williams
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

9.  Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics.

Authors:  George W Rutherford; William McFarland; Hilary Spindler; Karen White; Sadhna V Patel; John Aberle-Grasse; Keith Sabin; Nathan Smith; Stephanie Taché; Jesus M Calleja-Garcia; Rand L Stoneburner
Journal:  BMC Public Health       Date:  2010-07-29       Impact factor: 3.295

10.  Host sequence motifs shared by HIV predict response to antiretroviral therapy.

Authors:  William Dampier; Perry Evans; Lyle Ungar; Aydin Tozeren
Journal:  BMC Med Genomics       Date:  2009-07-23       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.